Meet our TEAM

Erik Martinsson (PhD)

CHIEF OPERATING OFFICER

Nathalie graduated from Linköping University in 2020 with a Master of Science in Industrial Engineering and Management. She is an impact-driven entrepreneur with a profound passion for start-ups working with new innovations and disruptive technologies. Prior to joining ArgusEye, Nathalie was enrolled in the business incubator LEAD working with over 30 start-up companies. As our COO, Nathalie is responsible for our daily operations, ensuring that we operate efficiently and work toward our goals

SENIOR R&D ENGINEER

Thuy is an experienced researcher with a PhD degree in analytical chemistry from Stockholm University developing a microfluidic method for characterization of therapeutic antibodies. After working at University of New Hampshire, USA for 1.5 years focusing on glycosylation analysis of biologics, she returned to Sweden and joined the group of Daniel Aili working with sensors for real-time monitoring of bioprocesses. Thuy joined ArgusEye during 2022 as a R&D engineer, focusing on product development and new applications for our sensor systems.

PRODUCT MANAGER

Motasam is a versatile professional with a background in research and industry, specializing in project and business management. He holds a master’s degree in Engineering Physics from KTH and a Licentiate degree in Biomedical Engineering Sciences from Linköping University. Currently pursuing a PhD in depth-resolved light scattering for melanoma detection, he is certified in Good Manufacturing Practice (GMP) and is committed to industry standards and quality management. Since joining ArgusEye in January 2023, Motasam has advanced to Product Manager, leveraging his technical expertise and business acumen to drive the development of next-generation sensor systems for biopharmaceutical applications.

APPLICATION SCIENTIST

Ana brings extensive expertise in molecular and biochemical analysis, with strong skills in gene editing, protein chemistry, and cell culture. She obtained her PhD in Molecular Biology from Stockholm University in 2022, where she explored the role of a metabolic protein in lung development. Ana has also been actively involved in quality control within the pharmaceutical industry. She joined ArgusEye in August 2024 as an Application Scientist, focusing on enabling customers to implement and optimize our cutting-edge sensor technologies.

R&D LAB ENGINEER

Jennifer graduated from Linköping University in 2024 with a Master of Science in Materials and Sensors in Biomedicine. During the spring of 2024, Jennifer wrote her master’s thesis at ArgusEye. She joined ArgusEye in August 2024 as an R&D Lab Engineer, focusing on product development and new applications for our sensor systems.

R&D LAB ENGINEER

Fernanda has broad experience in both research and industry. In 2024, she graduated from KTH with a Master of Science in Industrial and Environmental Biotechnology. Prior to that, she worked for several years as a Senior Research and Development Analyst, focusing on the development of clinical chemistry formulations and the optimization of quality control processes. In September 2024, Fernanda joined ArgusEye as an R&D Lab Engineer, focusing on product development and exploring new applications for our sensor systems.

R&D LAB ENGINEER

Jakob graduated from Linköping University in 2024 with a Master of Science in Sensors and Materials in Biomedicine. In September 2024, Jakob joined ArgusEye as an R&D Lab Engineer, focusing on product development and exploring new applications for our sensor systems.

COMMUNICATIONS OFFICER & COMMUNITY MANAGER

Elin joined ArgusEye in September 2024 as a Communications Officer and Community Manager, focusing on enhancing both our brand and our team.

PRODUCT DEVELOPER (CONSULTANT)

Sven has more than 40 years experience from product development of medical devices. Since 1991 he runs a consultant firm (Milton Medtech) that help companies and researchers with various support within prototyping, demonstration, certification, and production. Sven holds a BSc in Medical Technology from Linköping University and has been enrolled in ArgusEye since 2018.

CO-FOUNDER AND CHAIRMAN OF THE BOARD

Daniel has a background in Engineering Biology and did his PhD in Sensor Science at Linköping University (LiU), followed by postdocs at Imperial College London and the Center for Biomimetic Sensor Science at Nanyang Technological University, Singapore. He is a Wallenberg Academy Fellow and Professor in the Division of Biophysics and Bioengineering and Head of the Laboratory of Molecular Materials at LiU. His work spans from fundamental studies of molecular materials design to development of bioresponsive materials and devices, including biosensors, for applications in biomedicine and biotechnology.

BOARD MEMBER

Helena has a BA/BSc in Biology/Biochemistry and a broad marketing and product management experience after more than 30 years in the Life Science industry, from companies such as GE Healthcare (now Cytiva), Biacore (acquired by GE Healthcare) and Gyros Protein Technologies. In these roles she delivered product and marketing strategies for product portfolios ranging from capital instruments to high volume consumables. She has also successfully managed market introductions of new technologies and new product initiatives targeting pharmaceutical and biotech industries as well as academic research.

BOARD MEMBER

Allan is a market economist and chemical engineer with a focus on molecular biology/biochemistry and has many years of experience from various positions in the Swedish biotech/pharma industry. Since 2008 Allan holds a position as Investment Manager at ALMI Invest AB, a government funded seed investor.

BOARD MEMBER

Svante has a background in Finance with over 20-years experience from various roles in Banking and Capital Markets. Among other things he built the Securities Finance business in Nordea and he also led Nordeas global Equity Trading. The last years Svante has been working as a Business Advisor and Investor focusing mainly on small innovative companies in early phase.

CO-FOUNDER

CO-FOUNDER